社区居住老年人甘油三酯与痴呆风险的相关性:一项前瞻性队列研究
本研究基于ASPREE随机试验和UK Biobank前瞻性队列,纳入18,294名ASPREE参与者与68,200名UK Biobank参与者,分析基线甘油三酯与痴呆风险及认知变化的关系。结果显示甘油三酯水平升高与痴呆风险降低相关(ASPREE队列HR 0.82,95%CI 0.72-0.94),且与复合认知和记忆衰退较慢相关。
要点
- 在ASPREE队列中,甘油三酯每翻倍,痴呆风险HR为0.82(95%CI 0.72-0.94)。
- 在UK Biobank队列中,甘油三酯每翻倍,痴呆风险HR为0.83(p≤0.01)。
- 甘油三酯较高与复合认知和记忆随时间衰退较慢相关(p≤0.05)。
核心结论
- 在正常至正常高值范围内,甘油三酯水平较高的老年人相比甘油三酯较低者,痴呆风险更低且认知衰退更慢;较高的甘油三酯水平可能反映更好的整体健康状况和/或生活方式行为,未来研究需要探究血浆甘油三酯总量中的特定成分是否促进更好的认知功能。
研究设计与样本
- 前瞻性纵向研究,使用ASPREE随机试验中入组时无痴呆或既往心血管事件的65岁及以上成人数据,并在具有APOE-ε4遗传数据的亚队列及采用相似选择标准的UK Biobank外部队列中重复分析。
- 共纳入18,294名ASPREE参与者和68,200名UK Biobank参与者;ASPREE平均年龄75.1岁、女性56.3%、甘油三酯中位数106 mg/dL(四分位距80-142);UK Biobank平均年龄66.9岁、女性52.7%、甘油三酯中位数139 mg/dL(四分位距101-193)。
主要发现
- 中位随访6.4年和12.5年期间,ASPREE和UK Biobank分别记录823例和2,778例痴呆。
- 在ASPREE全队列中,甘油三酯水平较高与痴呆风险较低相关(甘油三酯翻倍的HR 0.82,95%CI 0.72-0.94)。
- 在具有APOE-ε4遗传数据的亚队列(n=13,976)中HR为0.82,在UK Biobank队列中HR为0.83,所有p≤0.01。
- 甘油三酯较高还与复合认知和记忆随时间衰退较慢相关(p≤0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来研究需要探究血浆甘油三酯总量中的特定成分是否促进更好的认知功能,以期为制定新的预防策略提供信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: It has been suggested that higher triglyceride levels were associated with a lower risk of Alzheimer disease. This study aimed to examine the association of triglycerides with dementia and cognition change in community-dwelling older adults. METHODS: This prospective longitudinal study used data from the Aspirin in Reducing Events in the Elderly (ASPREE) randomized trial of adults aged 65 years or older without dementia or previous cardiovascular events at enrollment. The main outcome was incident dementia. Other outcomes included changes in composite cognition and domain-specific cognition (global cognition, memory, language and executive function, and psychomotor speed). The association between baseline triglycerides and dementia risk was estimated using Cox proportional hazard models adjusting for relevant risk factors. Linear mixed models were used to investigate cognitive change. The analysis was repeated in a subcohort of participants with available APOE-ε4 genetic data with additional adjustment for APOE-ε4 carrier status and an external cohort (UK Biobank) with similar selection criteria applied. RESULTS: This study included 18,294 ASPREE participants and 68,200 UK Biobank participants (mean age: 75.1 and 66.9 years; female: 56.3% and 52.7%; median [interquartile range] triglyceride: 106 [80-142] mg/dL and 139 [101-193] mg/dL), with dementia recorded in 823 and 2,778 individuals over a median follow-up of 6.4 and 12.5 years, respectively. Higher triglyceride levels were associated with lower dementia risk in the entire ASPREE cohort (hazard ratio [HR] with doubling of triglyceride: 0.82, 95% CI 0.72-0.94). Findings were similar in the subcohort of participants with APOE-ε4 genetic data (n = 13,976) and in the UK Biobank cohort (HR was 0.82 and 0.83, respectively, all p ≤ 0.01). Higher triglycerides were also associated with slower decline in composite cognition and memory over time (p ≤ 0.05). DISCUSSION: Older adults with higher triglyceride levels within the normal to high-normal range had a lower dementia risk and slower cognitive decline over time compared with individuals with lower triglyceride levels. Higher triglyceride levels may be reflective of better overall health and/or lifestyle behaviors that would protect against dementia development. Future studies are warranted to investigate whether specific components within the total circulating pool of plasma triglycerides may promote better cognitive function, with the hope of informing the development of new preventive strategies.
引用
- Zhou Z, Ryan J, Tonkin AM, et al. Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study. Neurology. 2023. PMID: 37879942. doi:10.1212/WNL.0000000000207923
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。